SCHEMBL8286191

SCHEMBL8286191

COCCNCc1nc(C)cc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 4/20 0.37
PDE11A Q9HCR9 1/20 0.36
GAA P10253 4/20 0.35
MAPK1 P28482 3/20 0.35
HPGD P15428 3/20 0.35
NCF1 P14598 1/20 0.34
GLA P06280 2/20 0.34
ALDH1A1 P00352 4/20 0.33
LMNA P02545 3/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NSD2 O96028 1/20 0.33
IDO1 P14902 1/20 0.33
CRHBP P24387 1/20 0.33
TDO2 P48775 1/20 0.33
CASP7 P55210 1/20 0.33
CASP6 P55212 1/20 0.33
CRHR2 Q13324 1/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286190 0.86 MAPT (0.40) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286423 0.85 KCNH3 (0.42) KCNH3PDE11AGAAMAPK1HPGD
SCHEMBL8287190 0.85 PDE11A (0.40) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286140 0.84 PDE11A (0.37) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286460 0.84 PDE11A (0.43) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286575 0.83 PDE11A (0.38) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286421 0.82 PDE11A (0.39) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286424 0.81 MAT2A (0.41) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8362920 0.81 PDE11A (0.38) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8287610 0.81 PDE11A (0.39) PDE11AGAAMAPK1HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed